This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma (LEBEN)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Antonio Pinto, Fondazione Giovanni Pascale
ClinicalTrials.gov Identifier:
NCT01412307
First received: August 3, 2011
Last updated: August 8, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2016
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Publications:
http://meetinglibrary.asco.org/content/132091-144